
[ Fri, Feb 21st ]: TechCrunch
[ Fri, Feb 21st ]: IFLScience
[ Fri, Feb 21st ]: CNET
[ Fri, Feb 21st ]: kennesaw
[ Fri, Feb 21st ]: businessday
[ Fri, Feb 21st ]: businessday
[ Fri, Feb 21st ]: Reuters
[ Fri, Feb 21st ]: WKBW
[ Fri, Feb 21st ]: Forbes
[ Fri, Feb 21st ]: SpaceNews
[ Fri, Feb 21st ]: cnbctv18
[ Fri, Feb 21st ]: NextBigFuture
[ Fri, Feb 21st ]: Zawya
[ Fri, Feb 21st ]: Zawya
[ Fri, Feb 21st ]: MSN
[ Fri, Feb 21st ]: MSN

[ Thu, Feb 20th ]: Investopedia
[ Thu, Feb 20th ]: SignalSCV
[ Thu, Feb 20th ]: Reuters
[ Thu, Feb 20th ]: BBC
[ Thu, Feb 20th ]: NextBigFuture
[ Thu, Feb 20th ]: Politico
[ Thu, Feb 20th ]: techUK
[ Thu, Feb 20th ]: GeekWire
[ Thu, Feb 20th ]: Nature
[ Thu, Feb 20th ]: Wired
[ Thu, Feb 20th ]: digitalcameraworld
[ Thu, Feb 20th ]: manilatimes
[ Thu, Feb 20th ]: Yahoo
[ Thu, Feb 20th ]: Forbes
[ Thu, Feb 20th ]: AZoCleantech
[ Thu, Feb 20th ]: MSN
[ Thu, Feb 20th ]: MSN
[ Thu, Feb 20th ]: Zawya

[ Wed, Feb 19th ]: Yahoo
[ Wed, Feb 19th ]: WCJB
[ Wed, Feb 19th ]: kpax
[ Wed, Feb 19th ]: MLive
[ Wed, Feb 19th ]: NextBigFuture
[ Wed, Feb 19th ]: ABC
[ Wed, Feb 19th ]: Chronicle
[ Wed, Feb 19th ]: TechCrunch
[ Wed, Feb 19th ]: Inc
[ Wed, Feb 19th ]: Zawya
[ Wed, Feb 19th ]: news10nbc
[ Wed, Feb 19th ]: MSN
[ Wed, Feb 19th ]: ProPakistani
[ Wed, Feb 19th ]: Forbes
FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA


🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1 First-in-class novel PTH replacement therapy Australia becomes the first country to obtain Marketing Authorisation for YORVIPATH since FDA approval SINGAPORE,

Read the Full manilatimes Article at:
[ https://www.manilatimes.net/2025/02/21/tmt-newswire/pr-newswire/first-and-only-treatment-for-chronic-hypoparathyroidism-approved-in-australia/2059832 ]
Similar Science and Technology Publications
[ Fri, Dec 13th 2024 ]: The Globe and Mail